drug
as of 2026-07-01Luvadaxistat
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Neurocrine Biosciences
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
3
Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia
NCT05182476Phase 2Terminated
A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia
NCT03382639Phase 2Completed
A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia
NCT03359785Phase 2Completed
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
KOL
Clinical Development Lead
personKOL score —